Antischistosomal activity of hexadecyloxypropyl cyclic 9-(S)-[3-hydroxy-2- (phosphonomethoxy)propyl]adenine and other alkoxyalkyl esters of acyclic nucleoside phosphonates assessed by schistosome worm killing in vitro

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 12, 2009, Pages 5284-5287

  Botros, Sanaa S ^a   William, Samia ^a   Beadle, James R ^b   Valiaeva, Nadejda ^b   Hostetler, Karl Y ^b  

^a Giza   (Egypt)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACYCLIC NUCLEOSIDE; ANTIPROTOZOAL AGENT; CIDOFOVIR; ESTER DERIVATIVE; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMA MANSONI; WORM;

ADENINE; ANIMALS; CRICETINAE; MESOCRICETUS; MOLECULAR STRUCTURE; PHOSPHONIC ACIDS; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 71249140635     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00840-09     Document Type: Article

References (36)

1. Beadle, J. R., N. Rodriquez, K. A. Aldern, C. Hartline, E. Harden, E. R. Kern, and K. Y. Hostetler. 2002. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication, in vitro. Antimicrob. Agents Chemother. 46:2381-2386.
2. Beadle, J. R., W. B. Wan, S. L. Ciesla, K. A. Keith, C. Hartline, E. R. Kern, and K. Y. Hostetler. 2006. Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphono-methoxypropyl)adenine against cytomegalovirus and orthpoxviruses. J. Med. Chem. 49:2010-2015.
3. Blas, B. L., M. I. Rosales, I. L. Lipayon, K. Yasuraoka, H. Matsuda, and M. Hiyashi. 2004. The schistosomiasis problem in the Philippines: a review. Parasitol. Int. 53:127-134.
4. Botros, S., S. William, O. Hammam, Z. Zidek, and A. Holý. 2003. Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice. Antimicrob. Agents Chemother. 47:3853-3858.
5. Botros, S., and J. Bennett. 2007. Praziquantel resistance. Expert Opin. Drug Discov. 2(Suppl. 1):535-540.
6. Buller, R. M., G. Owens, J. Schriewer, L. Melman, J. R. Beadle, and K. Y. Hostetler. 2004. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. Virology 318:474-481.
7. Ciesla, S. L., J. Trahan, K. L. Winegarden, K. A. Aldern, G. R. Painter, and K. Y. Hostetler. 2003. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. Antivir. Res. 59:163-171.
8. De Clercq, E. 1991. Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonomethoxyalkylpurines and -pyrimidines. Biochem. Pharmacol. 42:963-972.
9. de Vries, E., J. G. Stam, F. F. Franssen, H. Niewenhuijs, P. Chavalitshewinkoon, E. De Clercq, J. P. Overdulve, and P. C. van der Vliet. 1991. Inhibition of the growth of Plasmodium falciparum and Plasmodium berghei by the DNA polymerase inhibitor HPMPA. Mol. Biochem. Parasitol. 47:43-50.
10. Doenhoff, M. J., and L. Pica-Mattoccia. 2006. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev. Antiinfect. Ther. 4:199-210.
11. Duvall, R. H., and W. B. DeWitt. 1967. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am. J. Trop. Med. Hyg. 16:483-486.
12. Fenwick, A., and J. P. Webster. 2006. Schistosomiasis: challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 19:577-582.
13. Gonnert, R., and P. Andrews. 1977. Praziquantel, a new broad spectrum antischistosomal agent. Z. Parasitenkd. 52:129-150.
14. Hartline, C. B., K. M. Gustin, W. B. Wan, S. L. Ciesla, J. R. Beadle, K. Y. Hostetler, and E. R. Kern. 2005. Activity of ether lipid ester prodrugs of acyclic nucleoside phosphonates against adenovirus replication in vitro. J. Infect. Dis. 191:396-399.
15. Holý, A., I. Votruba, A. Merta, J. Cerný, J. Veselý, J. Vlach, K. Sedivá, I. Rosenberg, M. Otmar, and H. Hrebabecký. 1990. Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antivir. Res. 13:295-311. (Pubitemid 20223544)
16. Hostetler, K. Y., K. A. Aldern, W. B. Wan, S. L. Ciesla, and J. R. Beadle. 2006. Alkoxyalkyl esters of (S)-9-[3-hydroxy-3-(phosphonomethoxy)propyl] adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro. Antimicrob. Agents Chemother. 50:2857-2859.
17. Hostetler, K. Y. 2009. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. Antivir. Res. 82:A84-A98.
18. Keiser, J., and J. Utzinger. 2007. Advances in the discovery and development of trematocidal drugs. Expert Opin. 2(1):S9-S13.
19. Keith, K. A., W. B. Wan, S. L. Ciesla, J. R. Beadle, K. Y. Hostetler, and E. R. Kern. 2004. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro. Antimicrob. Agents Chemother. 48:1869-1871.
20. Kern, E. R., C. Hartline, E. Harden, K. Keith, N. Rodriguez, J. R. Beadle, and K. Y. Hostetler. 2002. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. Antimicrob. Agents Chemother. 46:991-995.
21. Liang, Y. S., J. I. Bruce, and D. A. Boy. 1987. Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycle. Proc. First Sino-American Symp. 1:34-48.
22. Morrey, J. D., B. E. Korba, J. R. Beadle, D. L. Wyles, and K. Y. Hostetler. 2009. Alkoxyalkyl esters of 9-(S)-(3-hydroxy-2- phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo. Antimicrob. Agents Chemother. 53:2865-2870.
23. Painter, G. R., and K. Y. Hostetler. 2004. Design and development of oral drugs for the prophylaxis and treatment of smallpox infection. Trends Biotechnol. 22:423-427.
24. Quenelle, D. C., D. J. Collins, B. P. Herrod, K. A. Keith, J. Trahan, J. R. Beadle, K. Y. Hostetler, and E. R. Kern. 2007. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2-phosphonylmethoxy-propyl)adenine] [(S)-HPMPA] or octadecyloxy-ethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice. Antimicrob. Agents Chemother. 51:3940-3947.
25. Quenelle, D. C., D. J. Collins, K. Y. Hostetler, J. R. Beadle, W. B. Wan, and E. R. Kern. 2004. Oral treatment of cowpox and vaccinia infections in mice with ether lipid esters of cidofovir. Antimicrob. Agents Chemother. 48:404-412.
26. Quenelle, D. C., D. J. Collins, L. R. Pettway, C. B. Hartline, J. R. Beadle, W. B. Wan, K. Y. Hostetler, and E. R. Kern. 2008. Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus or human cytomegalovirus in animal models. Antivir. Res. 79:133-135.
27. Smeijsters, L. J., F. F. Franssen, L. Naesens, E. de Vries, A. Holý, J. Balzarini, E. De Clercq, and J. P. Overdulve. 1999. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates. Int. J. Antimicrob. Agents 12:53-61.
28. Southgate, V. R., D. Rollinson, L. A. Tchuem Tchuente, and P. Hagan. 2005. Towards control of schistosomiasis in sub-Saharan Africa. J. Helminthol. 79:181-185.
29. Steinmann, P., J. Keiser, R. Bos, M. Tanner, and J. Utzinger. 2006. Schistosomiasis and water resources development: systematic review, meta-analysis and estimates of people at risk. Lancet Infect. Dis. 6:411-425.
30. Utzinger, J., and J. Keiser. 2004. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 5:263-285.
31. Valiaeva, N., M. N. Prichard, R. M. Buller, J. R. Beadle, C. B. Hartline, J. Schriewer, J. Trahan, and K. Y. Hostetler. Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses. Antivir. Res., in press.
32. Van der Werf, M. J., S. J. de Vlas, S. Brooker, C. W. Looman, N. J. Nagelkerke, J. D. Habbema, and D. Engels. 2003. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86:125-139.
33. Wan, W. B., J. R. Beadle, C. B. Hartline, E. R. Kern, S. L. Ciesla, N. Valiaeva, and K. Y. Hostetler. 2005. Comparison of the antiviral activity of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro. Antimicrob. Agents Chemother. 49:656-662.
34. World Health Organization. 1993. The control of schistosomiasis. Second report of the W.H.O. Expert Committee. World Health Organization, Geneva, Switzerland.
35. World Health Organization. 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a W.H.O. expert committee. WHO Tech. Rep. Ser. 912. World Health Organization, Geneva, Switzerland.
36. Wyles, D. L., K. A. Kaihara, B. E. Korba, R. T. Schooley, J. R. Beadle, and K. Y. Hostetler. 2009. The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2- (phosphonomethoxy)propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B and 2A replicons. Antimicrob. Agents Chemother. 53:2660-2662.